SENORES

Senores Pharmaceuticals Limited

Pharmaceuticals

Share price

₹1,389

Market cap

₹6,389 Cr

1Y return

▲ 93%

A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.

Investors holding Senores Pharmaceuticals Limited

HSBC Mutual Fund

Mutual Fund

3.44%

AC

Astorne Capital

Foreign Investor

1.95%

Aditya Birla Sun Life Insurance

Institution

1.62%

ICICI Prudential Mutual Fund

Mutual Fund

1.37%

Recent moves 7

ICICI Prudential Mutual FundExited

ICICI Prudential Mutual Fund, which previously held 1.37 percent of Senores Pharmaceuticals Limited, has dropped off the company's disclosed shareholder list, indicating either a complete exit or a reduction below the 1 percent reporting threshold.

Aditya Birla Sun Life InsuranceDecreased

Aditya Birla Sun Life Insurance reduced its stake in Senores Pharmaceuticals from 2.96% to 1.62% by selling 617,002 shares. The value of shares sold is ₹86.68 Cr at ₹1405.10 apiece.

Astorne CapitalIncreased

Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares. The value of its increased holding is ₹12.93 Cr based on Senores Pharmaceuticals' share price of ₹1405.10.

HSBC Mutual FundIncreased

HSBC Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 2.29% to 3.44% by acquiring 527,314 additional shares. This change in holding is worth ₹74.1 Cr at the current share price of ₹1405.10.

Mahindra Manulife Mutual FundDecreased

Mahindra Manulife Mutual Fund decreased its stake in Senores Pharmaceuticals Limited from 1.40% to 1.14%, selling 123,337 shares for ₹17.34 Cr at ₹1405.10 apiece.

Bajaj Finserv Mutual FundNew position

Bajaj Finserv Mutual Fund acquired 5,48,914 shares of Senores Pharmaceuticals Limited, representing a 1.19% stake, valued at ₹77.12 crore.

5 promotersIncreased

Five promoters of Senores Pharmaceuticals acquired 11.7 lakh shares for ₹95.01 Cr at ₹812.00 apiece, bringing the promoter group's total stake in the company to 63.16%.

Track the whales in Senores Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.